ZINC CITRATE - CAP 30MG 30 MG
ZINC (ZINC CITRATE) : 30 MG · DIN 02205386 · SISU INC.
Health Canada status: CANCELLED POST MARKET
What is ZINC CITRATE - CAP 30MG?
ZINC CITRATE - CAP 30MG 30 MG contains ZINC (ZINC CITRATE) : 30 MG. It is listed in the Health Canada Drug Product Database under DIN 02205386, held by SISU INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02205386 |
|---|---|
| Brand name | ZINC CITRATE - CAP 30MG |
| Generic / active ingredient | ZINC (ZINC CITRATE) : 30 MG |
| Manufacturer | SISU INC. |
| Strength | 30 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12CB ZINC |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Jul-2006 |
| Original market date | 1996-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02205386 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2205386 |
| Brand name | ZINC CITRATE - CAP 30MG |
| Active ingredient / INN | ZINC (ZINC CITRATE) : 30 MG |
| ATC code | A12CB |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12 |
| AHFS class | 88:28.01* ; See footnote |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | SISU INC. |
Which pack is which?
| Strength on the label | 30 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is ZINC in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A12CB ZINC. 0 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ZINC 50 MG | 50 MG | TABLET | PREFERRED NUTRITION INC. | CANCELLED POST MARKET | DIN 02248879 |
| ZINC CITRATE CHELATE TAB 50MG | 50 MG | TABLET | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | DIN 00486930 |
| ZINC CITRATE TAB 15MG | 15 MG | TABLET | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | DIN 00875716 |
| ZINC LOZENGES WITH NON-MEDICINAL ECHINACEA | 5 MG | LOZENGE | HOLISTA HEALTH (CANADA) INC. | CANCELLED POST MARKET | DIN 02232574 |
| ZINC ORAL SPRAY | 5 MG | LIQUID | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 02243564 |
| ZINC TAB 15MG | 15 MG | TABLET | HALL LABORATORIES, LTD. | CANCELLED POST MARKET | DIN 00529850 |
| ZINC TAB 25MG HVP CHELATED | 25 MG | TABLET | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | DIN 00770736 |
| ZINC TABLETS 25MG | 25 MG | TABLET | ROYAL BODYCARE CANADA INC. | CANCELLED POST MARKET | DIN 01946749 |
| ZINCITRATE CAP 30MG | 30 MG | CAPSULE | PROFESSIONAL HEALTH PRODUCTS | CANCELLED POST MARKET | DIN 01950908 |
| ZN | 15 MG | TABLET | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00554618 |
Who else supplies ZINC worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ZINC appears in 38 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.